Syncom Formulations Shows Strong Growth Amidst Pharmaceutical Sector Challenges
Syncom Formulations (India) Ltd has demonstrated strong performance in the Pharmaceuticals & Biotechnology sector, achieving a 48.60% gain over the past year, significantly outperforming the Sensex. With a market capitalization of Rs 1,818.00 crore and a competitive P/E ratio, the company shows resilience and a solid market position.
Syncom Formulations (India) Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown a remarkable performance over the past year, with a gain of 48.60%, significantly outpacing the Sensex, which recorded a modest increase of 4.31%. Despite a slight decline of 0.99% today, the stock has demonstrated resilience with a robust 138.20% increase over the past three years and an impressive 977.97% rise over the last five years.In terms of technical indicators, the weekly MACD remains bullish, while the monthly outlook is mildly bearish. The Bollinger Bands indicate a mildly bullish trend on both weekly and monthly scales, suggesting some positive momentum. The daily moving averages also reflect a mildly bullish sentiment.
With a market capitalization of Rs 1,818.00 crore and a P/E ratio of 36.29, Syncom Formulations is positioned competitively within its industry, which has an average P/E of 36.07. This performance highlights the company's strong market position and its ability to navigate the challenges within the pharmaceutical landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
